Bach Christian, Tomova Elmira, Goldmann Katja, Weisbach Volker, Roesler Wolf, Mackensen Andreas, Winkler Julia, Spriewald Bernd M
Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Erlangen, Germany.
Transfus Med Hemother. 2015 Jan;42(1):38-45. doi: 10.1159/000370255. Epub 2014 Dec 22.
Sensitive and accurate methods to detect hematopoietic chimerism after hematopoietic stem cell transplantation (HSCT) are essential to evaluate engraftment and to monitor response to therapeutic procedures such as donor lymphocyte infusion. Continuous long-term follow up, however, requires large amounts of pre-HSCT samples limiting the application of many widely used techniques for sensitive chimerism monitoring.
DNAs from 42 normal healthy donors and 16 HSCT donor/recipient pairs were employed to validate the use of allele-specific insertion/deletion (indel) quantitative real-time polymerase chain reaction (qPCR) to quantify chimerism in samples with low amounts of DNA. Consequently, indel-qPCR analyses of samples from 16 HSCT patients were compared to short-tandem repeat (STR) specific PCR analyses.
Typing with reduced amounts of input DNA (15 vs. 60 ng) allowed for the reliable distinction of positive (mean threshold cycle (ct) 28.05) and negative (ct >36) signals. The high informativity of primer/probe sets, with 12 out of 19 markers exceeding 20% informativity, was confirmed in our cohort (n = 74). Importantly, a fourfold reduction of input DNA compared to published protocols did not alter PCR efficiencies and allowed for a more sensitive detection of chimerism in 7 of 16 HSCT patients compared to results obtained by STR-PCR.
Our data suggest that indel-qPCR is a more sensitive technique for the detection of hematopoietic chimerism compared to STR-PCR and works efficiently for samples with low amounts of DNA.
在造血干细胞移植(HSCT)后,用于检测造血嵌合体的灵敏且准确的方法对于评估植入情况以及监测对诸如供体淋巴细胞输注等治疗程序的反应至关重要。然而,持续的长期随访需要大量移植前样本,这限制了许多广泛使用的灵敏嵌合体监测技术的应用。
使用来自42名正常健康供体和16对HSCT供体/受体的DNA来验证等位基因特异性插入/缺失(indel)定量实时聚合酶链反应(qPCR)在低DNA含量样本中定量嵌合体的用途。随后,将16名HSCT患者样本的indel-qPCR分析结果与短串联重复序列(STR)特异性PCR分析结果进行比较。
使用减少量的输入DNA(15 ng与60 ng)进行分型能够可靠地区分阳性(平均熔解曲线温度(ct)28.05)和阴性(ct >36)信号。在我们的队列(n = 74)中证实了引物/探针组具有高信息性,19个标记中有12个超过20%的信息性。重要的是,与已发表方案相比,输入DNA减少四倍并未改变PCR效率,并且与STR-PCR结果相比,在16名HSCT患者中的7名患者中能够更灵敏地检测到嵌合体。
我们的数据表明,与STR-PCR相比,indel-qPCR是一种检测造血嵌合体更灵敏的技术,并且对于低DNA含量的样本能有效发挥作用。